Compare BMRN & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | HBM |
|---|---|---|
| Founded | 1996 | 1927 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 9.8B |
| IPO Year | 1999 | 2005 |
| Metric | BMRN | HBM |
|---|---|---|
| Price | $59.05 | $21.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 3 |
| Target Price | ★ $87.24 | $25.00 |
| AVG Volume (30 Days) | 2.1M | ★ 5.8M |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $13.34 | $29.94 |
| Revenue Next Year | $11.42 | $13.16 |
| P/E Ratio | $33.51 | ★ $21.47 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $5.95 |
| 52 Week High | $73.18 | $28.74 |
| Indicator | BMRN | HBM |
|---|---|---|
| Relative Strength Index (RSI) | 47.81 | 37.48 |
| Support Level | $56.08 | $14.25 |
| Resistance Level | $60.52 | $28.64 |
| Average True Range (ATR) | 2.28 | 1.30 |
| MACD | -0.28 | -0.60 |
| Stochastic Oscillator | 15.11 | 12.33 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.